miR-675 mediates downregulation of Twist1 and Rb in AFP-secreting hepatocellular carcinoma.
about
An overview of long non-coding RNAs in ovarian cancersMicroRNA Regulation of Epithelial to Mesenchymal TransitionThe role of the oncofetal H19 lncRNA in tumor metastasis: orchestrating the EMT-MET decisionThe H19 Long non-coding RNA in cancer initiation, progression and metastasis - a proposed unifying theoryCurrent Status of Long Non-Coding RNAs in Human Breast CancerNoncoding RNAs in Tumor Epithelial-to-Mesenchymal TransitionmiR-151-3p Targets TWIST1 to Repress Migration of Human Breast Cancer CellsModulation of miR-29 expression by α-fetoprotein is linked to the hepatocellular carcinoma epigenome.Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.Over-expression of miR-675 in formalin-fixed paraffin-embedded (FFPE) tissues of breast cancer patients.miR675 upregulates long noncoding RNA H19 through activating EGR1 in human liver cancer.H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b.H19-derived miR-675 contributes to bladder cancer cell proliferation by regulating p53 activationMiR675-5p Acts on HIF-1α to Sustain Hypoxic Responses: A New Therapeutic Strategy for GliomaH19 promotes endometrial cancer progression by modulating epithelial-mesenchymal transition.Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions.Twist in hepatocellular carcinoma: pathophysiology and therapeutics.miRNA for diagnosis and clinical implications of human hepatocellular carcinoma.The interplay between microRNAs and Twist1 transcription factor: a systematic review.MircoRNA-33a inhibits epithelial-to-mesenchymal transition and metastasis and could be a prognostic marker in non-small cell lung cancer.Sirtuin SIRT6 suppresses cell proliferation through inhibition of Twist1 expression in non-small cell lung cancer.The roles of microRNAs related with progression and metastasis in human cancers.The Interplay of LncRNA-H19 and Its Binding Partners in Physiological Process and Gastric CarcinogenesisLong Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells.Long non-coding RNAs in hepatocellular carcinoma: Potential roles and clinical implicationsTargeting H19, an Imprinted Long Non-Coding RNA, in Hepatic Functions and Liver DiseasesThe H19-PEG10/IGF2BP3 axis promotes gastric cancer progression in patients with high lymph node ratios.Regulation of Human Breast Cancer by the Long Non-Coding RNA H19.Reanalysis of microRNA expression profiles identifies novel biomarkers for hepatocellular carcinoma prognosis.Long Non-Coding RNAs in Obesity-Induced Cancer
P2860
Q26753467-092B15D9-61E8-4BB6-B509-185ACB865B10Q26771110-1800D257-BE24-40E0-A89F-EACD4B60E00DQ26775618-0A6C3614-B613-4509-ABF8-B49A5A9C2A3AQ26780223-4548C1CD-5EE9-4F7E-B481-00DC4B97CB19Q28079880-A2E17879-A277-48C1-A9C0-3F678DE8105BQ28080346-08BB347A-EDFD-4E09-9AD0-36DEE1C6D24AQ28588589-8F70A7F4-B59D-41D6-926D-A21BBEDDA0A2Q34098359-228B2F74-92F2-49B3-8945-9D2EFA625C08Q35357827-0E5DEDBE-6F33-4EB6-AE27-339F62582638Q36046557-19E96E90-E6B5-4C9E-AED4-9CD1686AE0B6Q36544748-8BC883C6-B172-4590-9670-27DC21444FA4Q36557258-5F51873F-3490-45B9-AF75-A72D7B70DBF6Q36827714-B4B8B00A-85B2-4908-BC10-D1124A00EB20Q36970349-8F3BB4E1-3E5E-4576-B320-76D3AEF3CD80Q37594042-3E9D314F-B6D2-47FE-BF78-15311563281FQ37681322-A3EF5F59-CFBE-4571-BB5B-13D569057692Q38504290-226920AD-F1CD-4A99-84AB-FB296BF8FCE7Q38568853-8BED8008-3AF2-4AB1-B342-BDA4BCDAD62CQ38735082-D5F01033-C760-40BF-8148-5071B3A5AF74Q38838791-A1E3761C-6F23-4502-A0BC-682D15D211E1Q38958874-9C39ED74-F449-4F36-BCE8-3E7CB1F2D5B3Q38974714-EAACD107-7DDA-4206-835F-D83A9C937280Q39147883-0329719C-A5DB-442C-B5ED-E02381538CA3Q39254523-9152364F-101A-421F-A4C8-D55766CF2774Q41608473-A526317F-3DEF-4469-AFA7-311C30C58DEDQ42226751-9F94EC5D-4C8C-4EFA-AD10-570EB8808E4CQ46207048-195C3670-55D4-404E-8606-85EA923C790BQ47110807-BA5344F5-ECF5-4C25-BECA-3506D7D68365Q51808126-D39A91A5-9305-4EC0-8F9E-371647406BB8Q58697396-50C415AD-945B-4527-B302-41EEC25F8D86
P2860
miR-675 mediates downregulation of Twist1 and Rb in AFP-secreting hepatocellular carcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
miR-675 mediates downregulatio ...... ting hepatocellular carcinoma.
@en
miR-675 mediates downregulatio ...... ting hepatocellular carcinoma.
@nl
type
label
miR-675 mediates downregulatio ...... ting hepatocellular carcinoma.
@en
miR-675 mediates downregulatio ...... ting hepatocellular carcinoma.
@nl
prefLabel
miR-675 mediates downregulatio ...... ting hepatocellular carcinoma.
@en
miR-675 mediates downregulatio ...... ting hepatocellular carcinoma.
@nl
P2093
P2860
P1476
miR-675 mediates downregulatio ...... ting hepatocellular carcinoma.
@en
P2093
J M Hernandez
L A Humphries
P2860
P2888
P304
P356
10.1245/S10434-013-3106-3
P478
20 Suppl 3
P577
2013-07-18T00:00:00Z
P6179
1017548803